Fundz

Cellino Closes $16M Seed Financing Led by The Engine and Khosla Ventures

PRIVATEFeb 01, 2021

Amount Raised

$16 Million

Round Type

Seed

CambridgeBiotechnologyTherapeutics

Description

Cellino, a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the closing of a $16M Seed financing round. The round was co-led by The Engine and Khosla Ventures, with participation from Humboldt Fund and 8VC.

Quick answer

Cellino Biotech raised $16 Million in a Seed round, dated February 1, 2021. Cellino Biotech is based in Cambridge, Massachusetts, United States.

How much did Cellino Biotech raise?
Cellino Biotech raised $16 Million in a Seed round on February 1, 2021.
What does Cellino Biotech do?
Cellino Biotech, Inc. is a preclinical biotechnology company that is focused on building an autonomous biomanufacturing platform for personalized regenerative medicine.
Where is Cellino Biotech based and how big is it?
Cellino Biotech is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Cellino Biotech?
Fundz holds 1 contact at Cellino Biotech. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Cellino Biotech that raised within 45 days of this round, from Fundz verified event records.

Who to call at Cellino Biotech, and when

A new round usually means Cellino Biotech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cellino Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cellino Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cellino Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cellino Biotech

Location

Cambridge, Massachusetts, United States

About

Cellino Biotech, Inc. is a preclinical biotechnology company that is focused on building an autonomous biomanufacturing platform for personalized regenerative medicine. The company aims to enable wide access to regenerative therapies with its ultra-scalable platform for personalized human cells.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cellino Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Cellino Biotech's next move

See what Strategic adds

Cellino Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.